Clinical Trials Directory

Trials / Unknown

UnknownNCT01615107

Premature Rupture of Mambrane and Unfavourable Cervix

Comparison Between the Use of Standard Oxytocin Induction Protocol and the Double-balloon Catheter Device With Concurrent Oxytocin

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Hillel Yaffe Medical Center · Other Government
Sex
Female
Age
16 Years – 50 Years
Healthy volunteers
Accepted

Summary

The paucity of published data concerning the issue of mechanical labor induction in the setting of Term PROM has led us to undertake the present clinical trial. This study is designed to compare the efficacy and safety of the standard Oxytocin induction protocol with the double-balloon catheter device with concurrent oxytocin administration in patients with Term PROM and unfavorable cervical conditions.

Detailed description

This will be a prospective randomised trial. Two hundred pregnant women with term PROM and an unfavourable cervix (Bishop Score ≤ 4) are expected to be entered into the study (see statistical analysis below). All eligible women will be presented with the study protocol by a study coordinator. Women interested in participating will read and sign the informed consent. Subsequently, the following screening medical procedures will be completed: medical and gynecological history, physical and vaginal examination, ultrasonography to: (i) Confirm fetal vertex presentation, (ii) Exclude placenta previa and (iii) Assess cervical length and posterior cervical angle. (iv) Asses bio-physical profile score A non-stress test will be performed in order to monitor: 1. The fetal heart pattern for the presence or absence of decelerations and 2. The presence of uterine contractions. All women will undergo a pelvic examination by a staff member to obtain an initial Bishop score. If the patient will be determined eligible for study entry, and following the informed consent, randomisation into the following groups will take place: GROUP 1: Oxytocin infusion alone (Standard Protocol). GROUP 2: insertion of the double balloon device and concurrent oxytocin administration. GROUP 3: Expectant management

Conditions

Interventions

TypeNameDescription
DEVICECOOK RIPENENIG BALLOON+PITOCNGROUP 2: insertion of the double balloon device and concurrent oxytocin administration.
DRUGPITOCIN: Oxytocin infusion alone (Standard Protocol
OTHERdouble balloonand oxytocinballoonand oxytocin
OTHERballon and oxytocindouble- balloon catheter device with concurrent oxytocin
PROCEDUREdouble balloonand and oxytocinballoon catheter device with concurrent oxytocin

Timeline

Start date
2012-07-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2012-06-08
Last updated
2012-06-08

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01615107. Inclusion in this directory is not an endorsement.